Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 17.28% is 23% above its 5-year average of 14.06%, near the high end of its 5-year range (11.70%–17.28%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.40% above its 12-month average of 16.24%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 17.28%.
RETURN ON EQUITY (ROE)
17.28%
RETURN ON EQUITY (ROE) AVG TTM
16.24%
RETURN ON EQUITY (ROE) AVG 3Y
14.64%
RETURN ON EQUITY (ROE) AVG 5Y
14.06%
RETURN ON EQUITY (ROE) AVG 10Y
14.38%
RETURN ON EQUITY (ROE) AVG 15Y
15.12%
RETURN ON EQUITY (ROE) AVG 20Y
15.37%
CURRENT VS TTM AVG
+6.40%
CURRENT VS 3Y AVG
+18.04%
CURRENT VS 5Y AVG
+22.90%
CURRENT VS 10Y AVG
+20.12%
CURRENT VS 15Y AVG
+14.25%
CURRENT VS 20Y AVG
+12.37%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+32.79%
vs the sector median at left
Intuitive Surgical, Inc.
Market Cap
$133.64B
Return on Equity (ROE)
17.28%
TTM Avg
16.24%
3Y Avg
14.64%
5Y Avg
14.06%
Market Cap
$131.17B
Return on Equity (ROE)
21.76%
TTM Avg
8.96%
3Y Avg
15.60%
5Y Avg
19.47%
Market Cap
$130.35B
Return on Equity (ROE)
41.59%
TTM Avg
-8.30%
3Y Avg
7.76%
5Y Avg
4.45%
Market Cap
$121.03B
Return on Equity (ROE)
10.41%
TTM Avg
9.71%
3Y Avg
8.51%
5Y Avg
8.44%
Market Cap
$120.79B
Return on Equity (ROE)
6.16%
TTM Avg
4.23%
3Y Avg
6.35%
5Y Avg
7.74%
Market Cap
$146.68B
Return on Equity (ROE)
7.61%
TTM Avg
7.38%
3Y Avg
9.51%
5Y Avg
10.24%
Market Cap
$157.28B
Return on Equity (ROE)
5.09%
TTM Avg
9.04%
3Y Avg
13.32%
5Y Avg
16.07%
Market Cap
$108.00B
Return on Equity (ROE)
15.55%
TTM Avg
14.50%
3Y Avg
15.05%
5Y Avg
14.30%
Market Cap
$104.65B
Return on Equity (ROE)
N/A
TTM Avg
-189.06%
3Y Avg
-180.53%
5Y Avg
3473.86%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intuitive Surgical, Inc. (ISRG) | $133.64B | 17.28% | 16.24% | 14.64% | 14.06% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $131.17B | 21.76% | 8.96% | 15.60% | 19.47% |
| Bristol-Myers Squibb Company (BMY)vs › | $130.35B | 41.59% | -8.30% | 7.76% | 4.45% |
| Medtronic plc (MDT)vs › | $121.03B | 10.41% | 9.71% | 8.51% | 8.44% |
| CVS Health Corp. (CVS)vs › | $120.79B | 6.16% | 4.23% | 6.35% | 7.74% |
| Danaher Corporation (DHR)vs › | $146.68B | 7.61% | 7.38% | 9.51% | 10.24% |
| Pfizer Inc. (PFE)vs › | $157.28B | 5.09% | 9.04% | 13.32% | 16.07% |
| Stryker Corporation (SYK)vs › | $108.00B | 15.55% | 14.50% | 15.05% | 14.30% |
| McKesson Corporation (MCK)vs › | $104.65B | N/A | -189.06% | -180.53% | 3473.86% |
| Sanofi (SNY)vs › | $102.44B | 5.82% | 9.06% | 9.15% | 10.86% |
ROE
17.3%
ROA
15.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 17.28% |
| 2026-03-31 | 17.05% |
| 2025-12-31 | 16.02% |
| 2025-09-30 | 16.23% |
| 2025-06-30 | 14.61% |
| 2025-03-31 | 14.47% |
| 2024-12-31 | 14.13% |
| 2024-09-30 | 14.39% |
| 2024-06-30 | 14.23% |
| 2024-03-31 | 14.24% |
| 2023-12-31 | 13.51% |
| 2023-09-30 | 12.10% |
| 2023-06-30 | 12.00% |
| 2023-03-31 | 11.70% |
| 2022-12-31 | 11.98% |
| 2022-09-30 | 11.97% |
| 2022-06-30 | 11.87% |
| 2022-03-31 | 13.52% |
| 2021-12-31 | 14.26% |
| 2021-09-30 | 14.74% |
| 2021-06-30 | 14.91% |
| 2021-03-31 | 11.51% |
| 2020-12-31 | 10.87% |
| 2020-09-30 | 11.34% |
| 2020-06-30 | 12.96% |
| 2020-03-31 | 16.25% |
| 2019-12-31 | 16.65% |
| 2019-09-30 | 16.90% |
| 2019-06-30 | 16.62% |
| 2019-03-31 | 16.29% |
| 2018-12-31 | 16.89% |
| 2018-09-30 | 12.67% |
| 2018-06-30 | 13.66% |
| 2018-03-31 | 13.94% |
| 2017-12-31 | 13.96% |
| 2017-09-30 | 18.20% |
| 2017-06-30 | 18.05% |
| 2017-03-31 | 18.88% |
| 2016-12-31 | 12.74% |
| 2016-09-30 | 13.03% |
| 2016-06-30 | 13.09% |
| 2016-03-31 | 13.22% |
| 2015-12-31 | 13.63% |
| 2015-09-30 | 13.26% |
| 2015-06-30 | 13.24% |
| 2015-03-31 | 13.15% |
| 2014-12-31 | 12.39% |
| 2014-09-30 | 14.21% |
| 2014-06-30 | 16.70% |
| 2014-03-31 | 14.40% |
| 2013-12-31 | 19.16% |
| 2013-09-30 | 20.82% |
| 2013-06-30 | 18.99% |
| 2013-03-31 | 18.61% |
| 2012-12-31 | 18.34% |
| 2012-09-30 | 19.22% |
| 2012-06-30 | 17.97% |
| 2012-03-31 | 18.26% |
| 2011-12-31 | 18.71% |
| 2011-09-30 | 19.63% |
| 2011-06-30 | 18.76% |
| 2011-03-31 | 17.96% |
| 2010-12-31 | 18.74% |
| 2010-09-30 | 16.84% |
| 2010-06-30 | 16.42% |
| 2010-03-31 | 16.37% |
| 2009-12-31 | 15.13% |
| 2009-09-30 | 14.80% |
| 2009-06-30 | 15.65% |
| 2009-03-31 | 15.97% |
| 2008-12-31 | 16.13% |
| 2008-09-30 | 17.13% |
| 2008-06-30 | 17.32% |
| 2008-03-31 | 16.86% |
| 2007-12-31 | 16.26% |
| 2007-09-30 | 14.88% |
| 2007-06-30 | 13.41% |
| 2007-03-31 | 12.65% |
| 2006-12-31 | 12.22% |
| 2006-09-30 | 18.01% |
| 2006-06-30 | 20.15% |
| 2006-03-31 | 21.23% |
| 2005-12-31 | 21.27% |
| 2005-09-30 | 14.79% |
| 2005-06-30 | 11.98% |
| 2005-03-31 | 9.61% |
| 2004-12-31 | 7.45% |
| 2004-09-30 | 2.32% |
| 2004-06-30 | -0.87% |
| 2004-03-31 | -2.28% |
| 2003-12-31 | -3.45% |
| 2003-09-30 | -3.60% |
| 2003-06-30 | -5.12% |
